NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2024-05-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1884db5f-72b5-6b0c-e063-6394a90a0e49 | 2024-05-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb08103-04ee-47a6-a9ad-290e169feb51 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | c8740506-c679-4c41-a96a-8ddbcddd72c6 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | abf2fe45-8b69-4d3c-981e-289c0aa3e98b | 2024-05-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c6ed6f74-0eca-4f99-8c7e-dd3f56167f01 | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Fosinopril Sodium and Hydrochlorothiazide | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 35019655-9a30-4305-a262-936ad0e73071 | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 50a58159-9572-4445-9859-b392632597da | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2024-04-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| PEMF Optimizer | AQUA SULIS, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, LAPIS ALBUS, MANGANUM METALLICUM VANADIUM METALLICUM VISCUM ALBUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 97d57469-4c5b-4d3f-9398-3a1a6617a649 | 2024-04-23 | Warnings | 059QF0KO0R |
| Enalapril maleate oral solution | ENALAPRIL MALEATE | NorthStar RxLLC | 19606da3-c6b0-40a5-9690-77fc37072b51 | 2024-04-18 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | cba87d5b-9302-7b2c-e053-2a95a90a7f9d | 2024-04-17 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 39d4dbd3-8f24-4898-a240-e94e06fa229a | 2024-04-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | WATER | Hikma Pharmaceuticals USA Inc. | 78ef7ad3-451d-43d0-a9b6-5cf0aadca003 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4c0b028d-f0f4-417f-a068-dca24e56113f | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | WATER | B. Braun Medical Inc. | 8fc8d87a-3951-4ac5-97df-c161ffc90475 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | a6ebafdc-4301-4d6c-b578-b3212648b13a | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ca13106-f68b-4894-aca2-03e74fff350c | 2024-04-03 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate | ENALAPRIL MALEATE | Bryant Ranch Prepack | 2061543d-67e7-46b6-aa56-cafa11ae4b93 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Eye Wash | WATER | M-star (Hubei) Health&Care Products Co., Ltd. | 71706039-e250-4f08-9687-71b2928c4e46 | 2024-04-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.